Your browser doesn't support javascript.
loading
Integrative pharmacology reveals the mechanisms of Erzhi Pill, a traditional Chinese formulation, against diabetic cardiomyopathy.
Peng, Mingming; Xia, Tianyi; Zhong, Yanmei; Zhao, Mantong; Yue, Yimin; Liang, Lanyuan; Zhong, Renxing; Zhang, Han; Li, Chuanqiu; Cao, Xia; Yang, Mengru; Wang, Yi; Shu, Zunpeng.
Afiliação
  • Peng M; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 945480350@qq.com.
  • Xia T; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: x791823593@qq.com.
  • Zhong Y; New Drug Research and Development Center, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: zhongyanmei33@163.com.
  • Zhao M; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 447568683@qq.com.
  • Yue Y; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 2694895700@qq.com.
  • Liang L; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 228660968@qq.com.
  • Zhong R; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 739559257@qq.com.
  • Zhang H; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Pharmacy, Jiamusi University, Jiamusi, 154007, China. Electronic address: 784908287@qq.com.
  • Li C; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 2419688073@qq.com.
  • Cao X; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 1301623198@qq.com.
  • Yang M; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 331977840@qq.com.
  • Wang Y; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: 784789997@qq.com.
  • Shu Z; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: shuzunpeng2010@163.com.
J Ethnopharmacol ; 296: 115474, 2022 Oct 05.
Article em En | MEDLINE | ID: mdl-35716918

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Cardiomiopatias Diabéticas Tipo de estudo: Prognostic_studies Limite: Animals País/Região como assunto: Asia Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Cardiomiopatias Diabéticas Tipo de estudo: Prognostic_studies Limite: Animals País/Região como assunto: Asia Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2022 Tipo de documento: Article